Wegovy is indicated for people ages 12 years and older who have: A BMI of 30 kg/m 2 or higher A BMI of 27 kg/m 2 to 29.9 kg/m 2 and at least one weight-related comorbidity , such as high blood pressure, type 2 diabetes, or obstructive sleep apnea Wegovy is also indicated to reduce the risk of major cardiovascular events , such as heart attack or stroke, in people who have obesity or overweight
Beyond weight management, these medications have also been linked to other health benefits, including lowering the risk of heart disease
Major insurers like UnitedHealthcare, Cigna, and others often cover these treatments when medically indicated
You can choose between an asynchronous or synchronous evaluation
Avoid or limit greasy, fried, and fatty meals, along with spicy foods